DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancer. - Harris FR; De Vitis LA; Grcevich L; Capasso I; Murphy SJ; Smadbeck JB; McCune AF; Ali MF; Karagouga G; Johnson SH; Sadeghian D; Schivardi G; et al. (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2026)